World Lung Cancer Day is a grassroots effort conceived by a lung cancer survivor. Here are a few updates on ways to prevent the disease and manage treatment.
Today is World Lung Cancer Day—a grassroots effort conceived by a lung cancer survivor, organizations around the world use the day to raise awareness on disease risks and treatment options. According to the National Cancer Institute, lung cancer is estimated to cause over 25% of all cancer deaths in the United States. That is a staggering number and one that could be lowered by sharing knowledge on preventive measures, early screening, and treatment options. Here are a few updates on the disease and its management:
1. Screening
A non-invasive tool is being developed for the early detection of lung cancer. Clinical trials in the United States and in England are evaluating a breathanalyzer that can measure volatile biomarkers in a person’s breath. The chip-based device is much smaller in size compared with a regular chemical analyzer and is expected to be much cheaper as well as easier to handle in the clinic, according to its developers.
With respect to coverage for the usual low-dose computed tomography (LDCT) screening, CMS declared that Medicare beneficiaries can receive LDCT screening once a year if they meet certain predetermined criteria.
2. Prevention
The importance of wellness and preventive measures is being realized across healthcare and a recent position statement by 2 organizations called for such an intervention to prevent lung cancer. The Society for Research on Nicotine and Tobacco and the Association for the Treatment of Tobacco Use and Dependence have recommended access to smoking cessation interventions for smokers in the high-risk group who undergo a lung cancer screen. One of the authors of the associated paper emphasize that those who get screened for lung cancer should be made aware of the multiple benefits of smoking cessation.
3. Research and Support
Cancer patients, survivors, and caregivers need support. Organizations like the Bonnie J. Addario Lung Cancer Foundation (ALCF) provide comprehensive support on the research and advocacy front for the cancer community. ALCF’s founder Bonnie Addario is a lung cancer survivor who, in an article in Evidence-Based Oncology, shared a novel approach of a remote clinical study participation platform. The trial, called the Genomics of Young Lung Study trial, is investigating mechanisms of lung cancer initiation and progression in those younger than 40 years of age around the globe.
4. Outcomes
The site where a patient receives treatment can influence survival, and institutional volume plays a significant role, according to a study published in the Journal of the National Cancer Institute. The study found that the 2-year survival rate of patients treated at high-volume centers was over 10% more than that of patients treated at low-volume centers. The authors believe that access to experts who treat lung cancer and a comprehensive team to manage the patient are important determinants of outcomes.
5. Treatment Updates
Several treatment options are available for the patient to choose from following discussions with the treating physician, based on the stage of disease and individual preference for outcomes from treatment. According to the Mayo Clinic, these options include surgery, chemotherapy, radiation therapy, targeted treatment, and palliative care.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More